EPG5 c.1007A > G mutation in a sibling pair with rapidly progressing Vici syndrome

8Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We report on a sibling pair with the EPG5 c.1007A > G mutation who developed a severe form of Vici syndrome and died in infancy. The c.1007A > G (p.Gln336Arg) mutation, affecting the penultimate nucleotide and the splicing of exon 2 is the most common mutation of EPG5 and is typically associated with a less devastating prognosis: cardiomyopathy and cataract are less frequent consequences and the median survival time is 78 months compared to an overall median survival of 42 months. The less severe course related to c.1007A > G was formerly explained by the preserved canonical splicing in 25% of the transcripts. In contrast, we found the messenger RNA encoded by the c.1007A > G allele to be absent, explaining the severe course of the disease. This family provides another example of phenotypic variability related to a differential splicing.

Cite

CITATION STYLE

APA

Vojcek, E., Keszthelyi, T. M., Jávorszky, E., Balogh, L., & Tory, K. (2020). EPG5 c.1007A > G mutation in a sibling pair with rapidly progressing Vici syndrome. Annals of Human Genetics, 84(1), 80–86. https://doi.org/10.1111/ahg.12337

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free